TABLE OF CONTENTS

Cancer Care Market Indicators: Implications of Changing Demographics and New Treatment Choices for Today’s Health Plans Gary M. Owens, MD

Cancer Drug Development: Barriers to Benefit Design in a Value-Driven Healthcare System Al B. Benson, III, MD, FACP

A Viable Value-Based Oncology Benefit Design Gary Rice, RPh, MS, MBA